OBJECTIVE:
To examine complications of cochlear implants using data from the Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database. METHOD: The MAUDE database was queried for all adverse events associated with cochlear implantation that were reported to the FDA during the year 1999 and the year 2009. The events were tabulated using a comprehensive list of categories. RESULTS: A total of 191 adverse events were identified for the year 1999, while 1115 adverse events were identified for the year 2009. For both years, the most frequently reported overall complication was unexplainable spontaneous device malfunction. The percentage of reported infections was significantly greater in 2009 (20%) as compared to 1999 (8%). Non-spontaneous (induced) malfunction was most commonly due to head injury, followed by surgical injury and damage from MRI, respectively. The most common complication spe-cifically due to error of surgical technique was electrode misplacement. The majority of flap problems reported were implant extrusion, infection, and excessive flap thickness. Migration of electrodes was most commonly associated with complaints of poor device performance, facial nerve stimulation, and pain. Less commonly reported complications included battery leakage and device explantation after recognition of an absent vestibulocochlear nerve. CONCLUSION: The design of the MAUDE database limits constructive comparisons between two time points, however provides for an extensive survey of both common and infrequent adverse events associated with cochlear implantation. Highlighting these complications may enable manufacturers, clinicians, and users to rapidly identify complications and to adopt techniques and modifications that may reduce these events.
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OBJECTIVE:
To assess the effect of the application of chorda tympani nerve in reconstruction of ossicular chain on improvement of hearing. METHOD: Medical histories of 141 cases (154 ears) undergoing tympanoplasty in our hospital between January 2000 and January 2004 and followed up over 12 months were retrospectively analyzed. The 141 cases were divided into three groups: chorda tympani nerve group (CTN group, chorda tympani nerve was used to spring and press the auricular bone, 41 ears), tympanic membrane group (TM group, tympanic membrane was used to spring and press the auricular bone, 72 ears) and gelatin sponge group (GS group, gelatin sponge was used to support the auricular bone, 41 ears). The therapeutic effect is considered successful if postoperative air-bone gap (ABG) is reduced within 20 dB; excellent if close up more is than 30 dB; effective if reduced more than 15dB. Preoperative and postoperative ABG were compared in each group, and the differences between preoperative and postoperative ABG were compared between the three groups. RESULTS: Twenty seven ears (66%), 12 ears (29%) and 33 ears (80%) were successful, excellent and effective in CTN group, respectively; 46 ears (64%), 16 ears (22%) and 52 ears (72%) in TM group; and 11 ears (27%), 8 (19.5%) and 23 (56%) in GS group. CONCLUSION: The chorda tympani nerve can fix the auricular bone to obtain good hearing improvement without requirement of secondary stages operation, and with no dysfunction of taste and facial nerve.
